Related Experiment Video
Updated: Jun 10, 2026

Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
2,3-Dihydroquinazolin-4(1H)-one derivatives as potent aldose reductase inhibitors: a combined experimental and
Feyzi Sinan Tokalı1, Yeliz Demir2, Nurgül Abul3
1Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, 36100 Kars, Türkiye.
Abstract:
A series of sixteen 2,3-dihydroquinazolin-4(1H)-one derivatives was designed and synthesized to evaluate their potential as aldose reductase (ALR2) inhibitors for the management of diabetic complications. The synthesized compounds were structurally characterized by FT-IR, NMR, and HRMS analyses, and their inhibitory activities were assessed through in vitro enzyme assays. All compounds exhibited notable ALR2 inhibition, with Ki values ranging from 0.052 to 1.272 μM. Among them, compound 9 demonstrated the highest potency (Ki = 0.052 μM), showing approximately 21-fold stronger activity than the reference inhibitor epalrestat (Ki = 1.124 μM). Structure-activity relationship analysis revealed that para-positioned electron-donating substituents and optimally positioned hydrogen-bond donor groups significantly enhance inhibitory activity, while ortho substitution adversely affects binding due to steric and conformational constraints. The most active inhibiyors exhibited low cytotoxicity against HUVEC cells, with IC50 values ranging from 36.18 to 55.41 μM, indicating that they are not cytotoxic at the concentrations required for effective ALR2 inhibition. Molecular docking and MM-GBSA analyses supported the experimental findings, indicating strong binding affinities for the most active compounds, particularly compounds 9 and 16. Molecular dynamics simulations further confirmed the stability of the 9-ALR2 complex, demonstrating low structural deviations and persistent interactions with key residues, including Trp-20, Val-47, His-110, Trp-219, and Leu-300. In addition, ADME and toxicity predictions suggested that the majority of the compounds possess favorable pharmacokinetic properties and low predicted toxicity profiles. These results highlight the 2,3-dihydroquinazolin-4(1H)-one scaffold as a promising framework for the development of potent ALR2 inhibitors.
Related Concept Videos
Phase I Reactions: Reductive Reactions
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
Preparation of Amines: Reductive Amination of Aldehydes and Ketones
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Preparation of Amines: Reduction of Oximes and Nitro Compounds
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Alcohols from Carbonyl Compounds: Reduction
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...
